4.7 Article

17p12 Influences Hematoma Volume and Outcome in Spontaneous Intracerebral Hemorrhage

Journal

STROKE
Volume 49, Issue 7, Pages 1618-1625

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/STROKEAHA.117.020091

Keywords

cerebral hemorrhage; genetics; genome-wide association study; humans; neuroimaging

Funding

  1. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke [K23NS086873, U01NS069763, R01NS093870, 5R01NS059727]
  2. Swedish Heart and Lung Foundation, Skane University Hospital, Region Skane
  3. Freemasons Lodge of Instruction EOS in Lund
  4. Foundation of Fars Frosta
  5. Lund University
  6. Swedish Stroke Association
  7. Spain Ministry of Health (Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III Federacion Espanola de Enfermedades Raras) [RD12/0042/0020]
  8. American Brain Foundation
  9. Massachusetts General Hospital Institute for Heart, Vascular, and Stroke Care
  10. Yale Pepper Scholar Award [P30AG021342]
  11. Neurocritical Care Society Research Fellowship

Ask authors/readers for more resources

Background and Purpose Hematoma volume is an important determinant of clinical outcome in spontaneous intracerebral hemorrhage (ICH). We performed a genome-wide association study (GWAS) of hematoma volume with the aim of identifying novel biological pathways involved in the pathophysiology of primary brain injury in ICH. Methods We conducted a 2-stage (discovery and replication) case-only genome-wide association study in patients with ICH of European ancestry. We utilized the admission head computed tomography to calculate hematoma volume via semiautomated computer-assisted technique. After quality control and imputation, 7 million genetic variants were available for association testing with ICH volume, which was performed separately in lobar and nonlobar ICH cases using linear regression. Signals with P<5x10(-8) were pursued in replication and tested for association with admission Glasgow coma scale and 3-month post-ICH dichotomized (0-2 versus 3-6) modified Rankin Scale using ordinal and logistic regression, respectively. Results The discovery phase included 394 ICH cases (228 lobar and 166 nonlobar) and identified 2 susceptibility loci: a genomic region on 22q13 encompassing PARVB (top single-nucleotide polymorphism rs9614326: , 1.84; SE, 0.32; P=4.4x10(-8)) for lobar ICH volume and an intergenic region overlying numerous copy number variants on 17p12 (top single-nucleotide polymorphism rs11655160: , 0.95; SE, 0.17; P=4.3x10(-8)) for nonlobar ICH volume. The replication included 240 ICH cases (71 lobar and 169 nonlobar) and corroborated the association for 17p12 (P=0.04; meta-analysis P=2.5x10(-9); heterogeneity, P=0.16) but not for 22q13 (P=0.49). In multivariable analysis, rs11655160 was also associated with lower admission Glasgow coma scale (odds ratio, 0.17; P=0.004) and increased risk of poor 3-month modified Rankin Scale (odds ratio, 1.94; P=0.045). Conclusions We identified 17p12 as a novel susceptibility risk locus for hematoma volume, clinical severity, and functional outcome in nonlobar ICH. Replication in other ethnicities and follow-up translational studies are needed to elucidate the mechanism mediating the observed association.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available